{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:51:03Z","timestamp":1772999463030,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JSPS KAKENHI","award":["15H04887"],"award-info":[{"award-number":["15H04887"]}]},{"name":"JSPS KAKENHI","award":["15K15415"],"award-info":[{"award-number":["15K15415"]}]},{"name":"JSPS KAKENHI","award":["15H04886"],"award-info":[{"award-number":["15H04886"]}]},{"name":"JSPS KAKENHI","award":["15K15414"],"award-info":[{"award-number":["15K15414"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["H26-itaku (nan)-ippan-027"],"award-info":[{"award-number":["H26-itaku (nan)-ippan-027"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"7th Rohto Dermatology Prize"},{"name":"Japanese Association of Geriatric Dermatology Research"},{"name":"Japanese Dermatological Association Basic Medicine Research Funds"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.jaut.2017.01.007","type":"journal-article","created":{"date-parts":[[2017,2,11]],"date-time":"2017-02-11T08:00:55Z","timestamp":1486800055000},"page":"28-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"special_numbering":"C","title":["Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA"],"prefix":"10.1016","volume":"80","author":[{"given":"Akitaka","family":"Shibata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazumitsu","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhide","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiko","family":"Mukumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Kaminuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.01.007_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1056\/NEJMoa1013068","article-title":"Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis","volume":"365","author":"Marrakchi","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.01.007_bib2","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/jid.2013.230","article-title":"The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist","volume":"133","author":"Sugiura","year":"2013","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib3","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/jid.2014.46","article-title":"CARD14 c.526G>C (p.Asp176His) is a significant risk factor for generalized pustular psoriasis with psoriasis vulgaris in the Japanese cohort","volume":"134","author":"Sugiura","year":"2014","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib4","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0001-7310(06)73412-3","article-title":"Generalized pustular psoriasis and cytolytic hepatitis associated with neutrophilic cholangitis","volume":"97","author":"Cabanillas","year":"2006","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.jaut.2017.01.007_bib5","doi-asserted-by":"crossref","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and initial characterization of four novel members of the interleukin-1 family","volume":"275","author":"Kumar","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.01.007_bib6","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1074\/jbc.275.2.1169","article-title":"Four new members expand the interleukin-1 superfamily","volume":"275","author":"Smith","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.01.007_bib7","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.4049\/jimmunol.1000313","article-title":"IL-1RL2 and its ligands contribute to the cytokine network in psoriasis","volume":"185","author":"Blumberg","year":"2010","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ni1110-973","article-title":"IL-1 family nomenclature","volume":"11","author":"Dinarello","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/08830189809043005","article-title":"Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist","volume":"16","author":"Dinarello","year":"1998","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib11","doi-asserted-by":"crossref","first-page":"4361","DOI":"10.4049\/jimmunol.1302959","article-title":"Interplay between CXCR2 and BLT1 facilitates neutrophil infiltration and resultant keratinocyte activation in a murine model of imiquimod-induced psoriasis","volume":"192","author":"Sumida","year":"2014","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib12","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.4049\/jimmunol.167.3.1440","article-title":"Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2","volume":"167","author":"Debets","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib13","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.M400117200","article-title":"Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs","volume":"279","author":"Towne","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.01.007_bib14","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.4049\/jimmunol.1003162","article-title":"IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression","volume":"186","author":"Johnston","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib15","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.immuni.2011.08.001","article-title":"Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation","volume":"35","author":"Cai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2017.01.007_bib17","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1172\/JCI63451","article-title":"Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk","volume":"122","author":"Tortola","year":"2012","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jaut.2017.01.007_bib18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tem.2010.08.007","article-title":"Toll-like receptors: linking inflammation to metabolism","volume":"22","author":"Konner","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.jaut.2017.01.007_bib19","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1038\/ncomms5711","article-title":"IL-37 protects against obesity-induced inflammation and insulin resistance","volume":"5","author":"Ballak","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2017.01.007_bib20","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/dvg.20614","article-title":"Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL\/6N mouse strain with high efficiency and stability","volume":"48","author":"Kiyonari","year":"2010","journal-title":"Genesis"},{"key":"10.1016\/j.jaut.2017.01.007_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.jid.5700487","article-title":"LEDGF\/DFS70, a major autoantigen of atopic dermatitis, is a component of keratohyalin granules","volume":"127","author":"Sugiura","year":"2007","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2222.2011.03847.x","article-title":"Selective down-regulation of Th2 cell-mediated airway inflammation in mice by pharmacological intervention of CCR4","volume":"42","author":"Kaminuma","year":"2012","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jaut.2017.01.007_bib23","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1038\/jid.2015.289","article-title":"Unprocessed Interleukin-36alpha regulates psoriasis-like skin inflammation in cooperation with Interleukin-1","volume":"135","author":"Milora","year":"2015","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib24","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.4049\/jimmunol.155.4.2158","article-title":"Chemokine binding and activities mediated by the mouse IL-8 receptor","volume":"155","author":"Lee","year":"1995","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib25","doi-asserted-by":"crossref","first-page":"29355","DOI":"10.1016\/S0021-9258(18)43882-3","article-title":"The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization","volume":"269","author":"Bozic","year":"1994","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.01.007_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","article-title":"Toll-like receptors and their crosstalk with other innate receptors in infection and immunity","volume":"34","author":"Kawai","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2017.01.007_bib27","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.bbrc.2009.08.062","article-title":"Toll-like receptors and innate immunity","volume":"388","author":"Kumar","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jaut.2017.01.007_bib28","doi-asserted-by":"crossref","first-page":"e111490","DOI":"10.1371\/journal.pone.0111490","article-title":"Autophagy, inflammation and innate immunity in inflammatory myopathies","volume":"9","author":"Cappelletti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.01.007_bib29","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/mol.105.019695","article-title":"A\u00a0novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling","volume":"69","author":"Ii","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jaut.2017.01.007_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/mol.110.068064","article-title":"TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules","volume":"79","author":"Matsunaga","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jaut.2017.01.007_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrrheum.2014.156","article-title":"Inflammation: IL-36 has proinflammatory effects in skin but not in joints","volume":"10","author":"Dietrich","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2017.01.007_bib32","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J.\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2017.01.007_bib34","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nm0307-242","article-title":"Cracking the cytokine code in psoriasis","volume":"13","author":"Nickoloff","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.01.007_bib35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/01.MIB.0000161305.81198.0f","article-title":"Association between Toll-like receptor 4 and inflammatory bowel disease","volume":"11","author":"Oostenbrug","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2017.01.007_bib36","first-page":"210","article-title":"Toll-like receptors: dysregulation in\u00a0vivo in patients with acute respiratory distress syndrome","volume":"51","author":"Ramirez Cruz","year":"2004","journal-title":"Rev. Alerg. Mex."},{"key":"10.1016\/j.jaut.2017.01.007_bib37","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0002-9440(10)64729-3","article-title":"Lipopolysaccharide pretreatment protects from renal ischemia\/reperfusion injury : possible connection to an interleukin-6-dependent pathway","volume":"156","author":"Heemann","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.01.007_bib38","doi-asserted-by":"crossref","first-page":"e90013","DOI":"10.1371\/journal.pone.0090013","article-title":"Lipopolysaccharide induces inflammatory hyperalgesia triggering a TLR4\/MyD88-dependent cytokine cascade in the mice paw","volume":"9","author":"Calil","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaut.2017.01.007_bib39","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ibd.21132","article-title":"Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohn's disease and murine colitis","volume":"16","author":"Pasternak","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jaut.2017.01.007_bib40","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","article-title":"Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1","volume":"4","author":"Mei","year":"2007","journal-title":"PLoS Med."},{"key":"10.1016\/j.jaut.2017.01.007_bib41","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1172\/JCI31008","article-title":"TLR4 activation mediates kidney ischemia\/reperfusion injury","volume":"117","author":"Wu","year":"2007","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.jaut.2017.01.007_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jaci.2013.06.022","article-title":"Innate sensors of pathogen and stress: linking inflammation to obesity","volume":"132","author":"Jin","year":"2013","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/08830189009056632","article-title":"Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action","volume":"6","author":"Freudenberg","year":"1990","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.01.007_bib44","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.01.007_bib45","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2012.08.015","article-title":"Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies","volume":"68","author":"Armstrong","year":"2013","journal-title":"J.\u00a0Am. Acad. Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib46","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1684\/ejd.2011.1452","article-title":"Psoriatic arthritis: from a dermatological perspective","volume":"21","author":"Yamamoto","year":"2011","journal-title":"Eur. J. Dermatol"},{"key":"10.1016\/j.jaut.2017.01.007_bib47","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.rdc.2015.07.006","article-title":"Etiology and pathogenesis of psoriatic arthritis","volume":"41","author":"Barnas","year":"2015","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"10.1016\/j.jaut.2017.01.007_bib48","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2340\/00015555-1833","article-title":"Current concepts in psoriatic arthritis: pathogenesis and management","volume":"94","author":"de Vlam","year":"2014","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.jaut.2017.01.007_bib49","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1097\/CCM.0b013e3181e7c5c9","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis","volume":"38","author":"Rice","year":"2010","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.01.007_bib50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000258674","article-title":"Increased serum levels of growth-related oncogene-alpha in patients with generalized pustular psoriasis","volume":"220","author":"Kato","year":"2010","journal-title":"Dermatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116303432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841116303432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:15:49Z","timestamp":1760256949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841116303432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":50,"alternative-id":["S0896841116303432"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.01.007","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toll-like receptor 4 antagonist TAK-242 inhibits autoinflammatory symptoms in DITRA","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}